Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03257267
Title Study of REGN2810 in Adults With Cervical Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications

cervical cancer

Therapies

Irinotecan

Gemcitabine

Vinorelbine

Pemetrexed Disodium

Cemiplimab

Topotecan

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN | BEL


No variant requirements are available.